Orally Disintegrating Selegiline in Parkinson Patients With Dopamine Agonist-Related Adverse Effects.
Lyons KE, Friedman JH, Hermanowicz N, Isaacson SH, Hauser RA, Hersh BP, Silver DE, Tetrud JW, Elmer LW, Parashos SA, Struck LK, Lew MF, Pahwa R.
Clin Neuropharmacol. 2009 Oct 22. [Epub ahead of print]PMID: 19855267 [PubMed - as supplied by publisher]Related articles